Metronidazole alone or with amoxicillin as adjuncts to non-surgical treatment of chronic periodontitis: a 1-year double-blinded, placebo-controlled, randomized clinical trial

Aim To evaluate the effects of the adjunctive use of metronidazole (MTZ) or MTZ + amoxicillin (AMX) in the treatment of generalized chronic periodontitis (ChP). A secondary aim was to examine a possible added effect of chlorhexidine to these therapies. Methods One hundred and eighteen subjects recei...

Full description

Saved in:
Bibliographic Details
Published inJournal of clinical periodontology Vol. 39; no. 12; pp. 1149 - 1158
Main Authors Feres, Magda, Soares, Geisla Mary Silva, Mendes, Juliana Alethusa Velloso, Silva, Maike Paulino, Faveri, Marcelo, Teles, Ricardo, Socransky, Sigmund S., Figueiredo, Luciene Cristina
Format Journal Article
LanguageEnglish
Published Oxford Blackwell Publishing Ltd 01.12.2012
Blackwell
Subjects
Online AccessGet full text
ISSN0303-6979
1600-051X
1600-051X
DOI10.1111/jcpe.12004

Cover

Abstract Aim To evaluate the effects of the adjunctive use of metronidazole (MTZ) or MTZ + amoxicillin (AMX) in the treatment of generalized chronic periodontitis (ChP). A secondary aim was to examine a possible added effect of chlorhexidine to these therapies. Methods One hundred and eighteen subjects received scaling and root planing (SRP) only or with MTZ [400 mg/thrice a day (TID)] or MTZ+AMX (500 mg/TID) for 14 days. Half of the subjects in each group rinsed with 0.12% chlorhexidine twice a day (BID) for 2 months. Subjects were clinically monitored at baseline, 3, 6 and 12‐months post‐therapy. Results The two antibiotic groups showed lower mean number of sites with probing depth (PD) ≥5 mm and fewer subjects exhibiting ≥9 of these sites at 1‐year post‐treatment. Logistic regression analysis showed that antibiotics were the only significant predictors of subjects presenting ≤4 sites with PD ≥5 mm at 1 year (MTZ+AMX: OR, 13.33; 95%CI, 3.75‐47.39/p = 0.0000; MTZ: OR, 7.26; 95%CI, 2.26‐23.30/p = 0.0004). The frequency of adverse events did not differ between the two antibiotic treatments (p > 0.05). The chlorhexidine subgroups showed a trend (p > 0.05) to present fewer residual sites ≥5 mm compared with the placebo subgroups at 1 year. Conclusion Treatment of generalized ChP is significantly improved by the adjunctive use of MTZ+AMX and MTZ. View the pubcast on this paper at http://scivee-1.sdsc.edu/node/55261
AbstractList Aim To evaluate the effects of the adjunctive use of metronidazole (MTZ) or MTZ + amoxicillin (AMX) in the treatment of generalized chronic periodontitis (ChP). A secondary aim was to examine a possible added effect of chlorhexidine to these therapies. Methods One hundred and eighteen subjects received scaling and root planing (SRP) only or with MTZ [400 mg/thrice a day (TID)] or MTZ+AMX (500 mg/TID) for 14 days. Half of the subjects in each group rinsed with 0.12% chlorhexidine twice a day (BID) for 2 months. Subjects were clinically monitored at baseline, 3, 6 and 12-months post-therapy. Results The two antibiotic groups showed lower mean number of sites with probing depth (PD) ≥5 mm and fewer subjects exhibiting ≥9 of these sites at 1-year post-treatment. Logistic regression analysis showed that antibiotics were the only significant predictors of subjects presenting ≤4 sites with PD ≥5 mm at 1 year (MTZ+AMX:OR, 13.33; 95%CI, 3.75-47.39/p = 0.0000; MTZ:OR, 7.26; 95%CI, 2.26-23.30/p = 0.0004). The frequency of adverse events did not differ between the two antibiotic treatments (p > 0.05). The chlorhexidine subgroups showed a trend (p > 0.05) to present fewer residual sites ≥5 mm compared with the placebo subgroups at 1 year. Conclusion Treatment of generalized ChP is significantly improved by the adjunctive use of MTZ+AMX and MTZ. View the pubcast on this paper at http://scivee-1.sdsc.edu/node/55261 [PUBLICATION ABSTRACT]
To evaluate the effects of the adjunctive use of metronidazole (MTZ) or MTZ + amoxicillin (AMX) in the treatment of generalized chronic periodontitis (ChP). A secondary aim was to examine a possible added effect of chlorhexidine to these therapies. One hundred and eighteen subjects received scaling and root planing (SRP) only or with MTZ [400 mg/thrice a day (TID)] or MTZ+AMX (500 mg/TID) for 14 days. Half of the subjects in each group rinsed with 0.12% chlorhexidine twice a day (BID) for 2 months. Subjects were clinically monitored at baseline, 3, 6 and 12-months post-therapy. The two antibiotic groups showed lower mean number of sites with probing depth (PD) ≥5 mm and fewer subjects exhibiting ≥9 of these sites at 1-year post-treatment. Logistic regression analysis showed that antibiotics were the only significant predictors of subjects presenting ≤4 sites with PD ≥5 mm at 1 year (MTZ+AMX: OR, 13.33; 95%CI, 3.75-47.39/p = 0.0000; MTZ: OR, 7.26; 95%CI, 2.26-23.30/p = 0.0004). The frequency of adverse events did not differ between the two antibiotic treatments (p > 0.05). The chlorhexidine subgroups showed a trend (p > 0.05) to present fewer residual sites ≥5 mm compared with the placebo subgroups at 1 year. Treatment of generalized ChP is significantly improved by the adjunctive use of MTZ+AMX and MTZ.
View the pubcast on this paper at http://scivee-1.sdsc.edu/node/55261
Aim To evaluate the effects of the adjunctive use of metronidazole (MTZ) or MTZ + amoxicillin (AMX) in the treatment of generalized chronic periodontitis (ChP). A secondary aim was to examine a possible added effect of chlorhexidine to these therapies. Methods One hundred and eighteen subjects received scaling and root planing (SRP) only or with MTZ [400 mg/thrice a day (TID)] or MTZ+AMX (500 mg/TID) for 14 days. Half of the subjects in each group rinsed with 0.12% chlorhexidine twice a day (BID) for 2 months. Subjects were clinically monitored at baseline, 3, 6 and 12‐months post‐therapy. Results The two antibiotic groups showed lower mean number of sites with probing depth (PD) ≥5 mm and fewer subjects exhibiting ≥9 of these sites at 1‐year post‐treatment. Logistic regression analysis showed that antibiotics were the only significant predictors of subjects presenting ≤4 sites with PD ≥5 mm at 1 year (MTZ+AMX: OR, 13.33; 95%CI, 3.75‐47.39/p = 0.0000; MTZ: OR, 7.26; 95%CI, 2.26‐23.30/p = 0.0004). The frequency of adverse events did not differ between the two antibiotic treatments (p > 0.05). The chlorhexidine subgroups showed a trend (p > 0.05) to present fewer residual sites ≥5 mm compared with the placebo subgroups at 1 year. Conclusion Treatment of generalized ChP is significantly improved by the adjunctive use of MTZ+AMX and MTZ. View the pubcast on this paper at http://scivee-1.sdsc.edu/node/55261
To evaluate the effects of the adjunctive use of metronidazole (MTZ) or MTZ + amoxicillin (AMX) in the treatment of generalized chronic periodontitis (ChP). A secondary aim was to examine a possible added effect of chlorhexidine to these therapies.AIMTo evaluate the effects of the adjunctive use of metronidazole (MTZ) or MTZ + amoxicillin (AMX) in the treatment of generalized chronic periodontitis (ChP). A secondary aim was to examine a possible added effect of chlorhexidine to these therapies.One hundred and eighteen subjects received scaling and root planing (SRP) only or with MTZ [400 mg/thrice a day (TID)] or MTZ+AMX (500 mg/TID) for 14 days. Half of the subjects in each group rinsed with 0.12% chlorhexidine twice a day (BID) for 2 months. Subjects were clinically monitored at baseline, 3, 6 and 12-months post-therapy.METHODSOne hundred and eighteen subjects received scaling and root planing (SRP) only or with MTZ [400 mg/thrice a day (TID)] or MTZ+AMX (500 mg/TID) for 14 days. Half of the subjects in each group rinsed with 0.12% chlorhexidine twice a day (BID) for 2 months. Subjects were clinically monitored at baseline, 3, 6 and 12-months post-therapy.The two antibiotic groups showed lower mean number of sites with probing depth (PD) ≥5 mm and fewer subjects exhibiting ≥9 of these sites at 1-year post-treatment. Logistic regression analysis showed that antibiotics were the only significant predictors of subjects presenting ≤4 sites with PD ≥5 mm at 1 year (MTZ+AMX: OR, 13.33; 95%CI, 3.75-47.39/p = 0.0000; MTZ: OR, 7.26; 95%CI, 2.26-23.30/p = 0.0004). The frequency of adverse events did not differ between the two antibiotic treatments (p > 0.05). The chlorhexidine subgroups showed a trend (p > 0.05) to present fewer residual sites ≥5 mm compared with the placebo subgroups at 1 year.RESULTSThe two antibiotic groups showed lower mean number of sites with probing depth (PD) ≥5 mm and fewer subjects exhibiting ≥9 of these sites at 1-year post-treatment. Logistic regression analysis showed that antibiotics were the only significant predictors of subjects presenting ≤4 sites with PD ≥5 mm at 1 year (MTZ+AMX: OR, 13.33; 95%CI, 3.75-47.39/p = 0.0000; MTZ: OR, 7.26; 95%CI, 2.26-23.30/p = 0.0004). The frequency of adverse events did not differ between the two antibiotic treatments (p > 0.05). The chlorhexidine subgroups showed a trend (p > 0.05) to present fewer residual sites ≥5 mm compared with the placebo subgroups at 1 year.Treatment of generalized ChP is significantly improved by the adjunctive use of MTZ+AMX and MTZ.CONCLUSIONTreatment of generalized ChP is significantly improved by the adjunctive use of MTZ+AMX and MTZ.
Author Soares, Geisla Mary Silva
Faveri, Marcelo
Socransky, Sigmund S.
Feres, Magda
Silva, Maike Paulino
Teles, Ricardo
Mendes, Juliana Alethusa Velloso
Figueiredo, Luciene Cristina
Author_xml – sequence: 1
  givenname: Magda
  surname: Feres
  fullname: Feres, Magda
  email: Address:, mferes@ung.br
  organization: Department of Periodontology, Dental Research Division, Guarulhos University, São Paulo, Guarulhos, Brazil
– sequence: 2
  givenname: Geisla Mary Silva
  surname: Soares
  fullname: Soares, Geisla Mary Silva
  organization: Department of Periodontology, Dental Research Division, Guarulhos University, São Paulo, Guarulhos, Brazil
– sequence: 3
  givenname: Juliana Alethusa Velloso
  surname: Mendes
  fullname: Mendes, Juliana Alethusa Velloso
  organization: Department of Periodontology, Dental Research Division, Guarulhos University, São Paulo, Guarulhos, Brazil
– sequence: 4
  givenname: Maike Paulino
  surname: Silva
  fullname: Silva, Maike Paulino
  organization: Department of Periodontology, Dental Research Division, Guarulhos University, São Paulo, Guarulhos, Brazil
– sequence: 5
  givenname: Marcelo
  surname: Faveri
  fullname: Faveri, Marcelo
  organization: Department of Periodontology, Dental Research Division, Guarulhos University, São Paulo, Guarulhos, Brazil
– sequence: 6
  givenname: Ricardo
  surname: Teles
  fullname: Teles, Ricardo
  organization: The Forsyth Institute, Cambridge, MA, USA
– sequence: 7
  givenname: Sigmund S.
  surname: Socransky
  fullname: Socransky, Sigmund S.
  organization: The Forsyth Institute, MA, Cambridge, USA
– sequence: 8
  givenname: Luciene Cristina
  surname: Figueiredo
  fullname: Figueiredo, Luciene Cristina
  organization: Department of Periodontology, Dental Research Division, Guarulhos University, São Paulo, Guarulhos, Brazil
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=26674088$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/23016867$$D View this record in MEDLINE/PubMed
BookMark eNp9kt9u0zAUxiM0xLrBDQ-ALCEkhMiw48RJuEPVKKAykPgz7qwT-4S5c-NiO9q6h-IZcWkL0oTwjS3r930-5_g7yg4GN2CWPWT0hKX1YqFWeMIKSss72YQJSnNasW8H2YRyynPR1u1hdhTCglJWc87vZYcFp0w0op5kP99j9G4wGm6cRQI2WRPnyZWJFwSW7tooY60ZCAQCejEOKgYSHUkl5GH0340CS6JHiEscInE9URcbP0VW6I3TbogmmvCSAGH5GsET7cbOYt4lU436OVlZUNi5XCXUO2s3dx4G7ZbmBjVRids9YsDez-72YAM-2O3H2ZfXp5-nb_L5h9nb6at5rsq2LPOeApa60EqXgpbYYUELVQnedy2UoHivlWqgVlpV6dx2GqFqO6waXjdViSU_zp5ufVfe_RgxRLk0QaG1MKAbg2SsZo2oalEk9PEtdOFGP6TqJCs5b-pCCJGoRztq7Jao5cqbJfi13P9EAp7sAAip3T6NQJnwlxOiLmnTJI5uOeVdCB57qUyEaDbTA2Mlo3ITCrkJhfwdiiR5dkuyd_0nzLbwlbG4_g8p300_nu41-VZjQsTrPxrwlzJ1Vlfy_Gwmv85n50VDP8kz_gstLNpb
CitedBy_id crossref_primary_10_1111_jcpe_12995
crossref_primary_10_1111_jcpe_12994
crossref_primary_10_1002_JPER_22_0301
crossref_primary_10_1111_jcpe_12076
crossref_primary_10_1007_s00784_020_03198_4
crossref_primary_10_1002_JPER_20_0764
crossref_primary_10_1177_0022034516639274
crossref_primary_10_1186_1472_6831_14_159
crossref_primary_10_47820_recima21_v5i11_5843
crossref_primary_10_1002_JPER_22_0657
crossref_primary_10_1016_j_mimet_2015_01_023
crossref_primary_10_1111_adj_12674
crossref_primary_10_1002_14651858_CD012568
crossref_primary_10_1080_08927014_2022_2160242
crossref_primary_10_1016_j_pdpdt_2016_11_016
crossref_primary_10_1007_s00784_020_03292_7
crossref_primary_10_4103_tdj_tdj_38_24
crossref_primary_10_1111_idh_12438
crossref_primary_10_1111_jcpe_13824
crossref_primary_10_1186_s13063_018_2540_8
crossref_primary_10_3390_jcm11113189
crossref_primary_10_1111_jcpe_12217
crossref_primary_10_1902_jop_2013_130278
crossref_primary_10_1111_jcpe_13547
crossref_primary_10_3892_etm_2019_7856
crossref_primary_10_1111_jcpe_12578
crossref_primary_10_1016_j_atherosclerosis_2020_09_019
crossref_primary_10_1111_jcpe_12299
crossref_primary_10_1111_jcpe_13264
crossref_primary_10_3389_fmicb_2023_1122051
crossref_primary_10_1111_jcpe_14082
crossref_primary_10_1002_14651858_CD012568_pub2
crossref_primary_10_1590_1678_7757_2023_ed001
crossref_primary_10_1016_S0022_3913_13_60358_3
crossref_primary_10_1111_jre_13093
crossref_primary_10_1177_2040622320919621
crossref_primary_10_1590_1678_775720140453
crossref_primary_10_1111_jcpe_13704
crossref_primary_10_1111_jphp_12161
crossref_primary_10_1371_journal_pone_0179592
crossref_primary_10_1111_jcpe_14003
crossref_primary_10_1111_jcpe_13551
crossref_primary_10_1111_jre_12821
crossref_primary_10_1111_prd_12358
crossref_primary_10_1111_prd_12075
crossref_primary_10_1186_s13063_021_05246_0
crossref_primary_10_1007_s00784_018_2398_x
crossref_primary_10_1902_jop_2014_140478
crossref_primary_10_1111_prd_12235
crossref_primary_10_1016_j_adaj_2017_01_021
crossref_primary_10_1111_jcpe_13838
crossref_primary_10_1902_jop_2013_130142
crossref_primary_10_1016_j_jphotobiol_2017_08_012
crossref_primary_10_1111_jcpe_12559
crossref_primary_10_1111_jre_12252
crossref_primary_10_1590_1807_3107bor_2024_vol38_0121
crossref_primary_10_1007_s00784_015_1499_z
crossref_primary_10_1590_1807_3107bor_2021_vol35_0100
crossref_primary_10_5005_jp_journals_10024_3316
crossref_primary_10_1111_jcpe_12155
crossref_primary_10_1111_jcpe_12793
crossref_primary_10_1016_j_pdpdt_2020_101688
crossref_primary_10_1111_prd_12121
crossref_primary_10_1902_jop_2015_140620
crossref_primary_10_1111_idh_12347
crossref_primary_10_1111_cns_70152
crossref_primary_10_1111_odi_14786
crossref_primary_10_1111_adj_12991
crossref_primary_10_15171_jlms_2017_25
crossref_primary_10_4103_jisp_jisp_26_24
crossref_primary_10_1016_j_clinthera_2021_10_016
crossref_primary_10_1111_jcpe_12721
crossref_primary_10_1111_jcpe_13777
crossref_primary_10_1111_jre_12089
crossref_primary_10_3390_antibiotics9020068
crossref_primary_10_1111_jcpe_12441
crossref_primary_10_1111_jcpe_12282
crossref_primary_10_1111_jcpe_13096
crossref_primary_10_1007_s40496_019_00225_6
crossref_primary_10_1007_s00784_018_2392_3
crossref_primary_10_1007_s40496_019_0216_4
crossref_primary_10_1111_prd_12492
crossref_primary_10_3390_genes9060271
crossref_primary_10_3390_antibiotics11010009
crossref_primary_10_1111_jcpe_13464
crossref_primary_10_1002_14651858_CD008676_pub2
crossref_primary_10_1002_JPER_20_0196
crossref_primary_10_1002_JPER_18_0399
crossref_primary_10_3390_antibiotics9100686
crossref_primary_10_1111_adj_12415
crossref_primary_10_1002_cre2_48
crossref_primary_10_1590_1678_7757_2021_0583
crossref_primary_10_1007_s00784_019_02927_8
crossref_primary_10_1111_jre_12221
crossref_primary_10_1128_AAC_04974_14
crossref_primary_10_1186_s12903_015_0123_6
crossref_primary_10_1111_jre_13272
crossref_primary_10_1016_j_identj_2022_11_018
crossref_primary_10_1038_s41598_020_73054_8
crossref_primary_10_17816_KMJ2020_356
crossref_primary_10_1007_s00784_014_1193_6
crossref_primary_10_1039_D0MD00424C
crossref_primary_10_1016_j_adaj_2014_12_015
crossref_primary_10_1080_20002297_2023_2213111
crossref_primary_10_1007_s40496_019_00224_7
crossref_primary_10_1111_omi_12459
crossref_primary_10_1007_s41547_019_00063_w
crossref_primary_10_1007_s00784_014_1208_3
crossref_primary_10_3390_microorganisms10112172
crossref_primary_10_1016_j_jebdp_2014_04_025
Cites_doi 10.1111/j.1600-051X.2008.01304.x
10.1111/j.1600-0765.1987.tb01574.x
10.1902/jop.1991.62.4.247
10.1902/jop.1984.55.6.325
10.1177/0022034510374737
10.1902/annals.2003.8.1.115
10.1111/j.1600-051X.2004.00605.x
10.1034/j.1600-051x.2001.028007597.x
10.1902/jop.2010.090522
10.1111/j.1600-051X.2006.00905.x
10.1902/jop.2009.080540
10.1111/j.1600-051X.2011.01763.x
10.1111/j.1600-051X.2008.01245.x
10.1034/j.1600-051X.29.s3.8.x
10.1111/j.1875-595X.2003.tb00770.x
10.14219/jada.archive.2003.0225
10.1034/j.1600-051x.2001.028004296.x
10.1111/j.1600-051X.2011.01795.x
10.1111/j.1600-051X.2009.01471.x
10.1111/j.1600-051X.2012.01870.x
10.1111/j.1600-051X.2005.00814.x
10.1111/j.1600-051X.2006.01040.x
10.1111/j.1600-051X.2009.01508.x
10.1902/annals.1999.4.1.1
10.1034/j.1600-051X.2002.290410.x
10.1111/j.1600-051X.1989.tb01626.x
10.1111/j.1600-051X.2011.01766.x
10.1902/jop.2005.76.5.749
10.1111/j.1600-051X.2010.01538.x
ContentType Journal Article
Copyright 2012 John Wiley & Sons A/S
2014 INIST-CNRS
2012 John Wiley & Sons A/S.
Copyright © 2012 John Wiley & Sons A/S
Copyright_xml – notice: 2012 John Wiley & Sons A/S
– notice: 2014 INIST-CNRS
– notice: 2012 John Wiley & Sons A/S.
– notice: Copyright © 2012 John Wiley & Sons A/S
DBID BSCLL
AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7QP
K9.
7X8
DOI 10.1111/jcpe.12004
DatabaseName Istex
CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Calcium & Calcified Tissue Abstracts
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Health & Medical Complete (Alumni)
Calcium & Calcified Tissue Abstracts
MEDLINE - Academic
DatabaseTitleList ProQuest Health & Medical Complete (Alumni)
MEDLINE
CrossRef

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Dentistry
EISSN 1600-051X
EndPage 1158
ExternalDocumentID 3076290771
23016867
26674088
10_1111_jcpe_12004
JCPE12004
ark_67375_WNG_VLGW280S_N
Genre article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: Fundação de Amparo à Pesquisa do Estado de São Paulo
GroupedDBID ---
.3N
.GA
.Y3
05W
0R~
10A
1OB
1OC
29K
31~
33P
34H
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52S
52T
52U
52V
52W
52X
53G
5GY
5HH
5LA
5RE
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A03
AAESR
AAEVG
AAHHS
AANLZ
AAONW
AASGY
AAWTL
AAXRX
AAZKR
ABCQN
ABCUV
ABEML
ABJNI
ABLJU
ABOCM
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFO
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACSCC
ACXBN
ACXQS
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFEBI
AFFNX
AFFPM
AFGKR
AFPWT
AFZJQ
AHBTC
AHEFC
AHMBA
AIACR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BSCLL
BY8
C45
CAG
COF
CS3
CWXXS
D-E
D-F
D-I
DC6
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
EBS
EJD
F00
F01
F04
F5P
FEDTE
FUBAC
FZ0
G-S
G.N
GODZA
H.T
H.X
HF~
HGLYW
HVGLF
HZI
HZ~
IHE
IX1
J0M
K48
KBYEO
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MJL
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
OVD
P2P
P2W
P2X
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
R.K
RIWAO
RJQFR
ROL
RX1
SAMSI
SUPJJ
TEORI
UB1
UMD
V8K
V9Y
W8V
W99
WBKPD
WBNRW
WIH
WIJ
WIK
WOHZO
WPGGZ
WQJ
WRC
WXSBR
XG1
YFH
YOC
YOJ
YUY
ZGI
ZXP
ZZTAW
~IA
~WT
AAHQN
AAIPD
AAMMB
AAMNL
AANHP
AAYCA
ACRPL
ACYXJ
ADNMO
AEFGJ
AEYWJ
AFWVQ
AGHNM
AGQPQ
AGXDD
AGYGG
AIDQK
AIDYY
ALVPJ
AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7QP
K9.
7X8
ID FETCH-LOGICAL-c4944-f0ae4d2dcd4604ebe202c563fb9a4ac3fdcc8a7cdc53fd9bdea59be5837854e43
IEDL.DBID DR2
ISSN 0303-6979
1600-051X
IngestDate Thu Jul 10 17:06:45 EDT 2025
Fri Jul 25 18:50:44 EDT 2025
Mon Jul 21 06:03:26 EDT 2025
Mon Jul 21 09:10:53 EDT 2025
Thu Apr 24 23:04:06 EDT 2025
Tue Jul 01 01:38:40 EDT 2025
Wed Aug 20 07:26:30 EDT 2025
Wed Oct 30 09:55:03 EDT 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 12
Keywords Nitro compound
Imidazole derivatives
scaling and root planing
Stomatology
β-Lactams
chronic periodontitis
periodontal treatment
Dentistry
Penicillin derivatives
Tooth root
Antiprotozoal agent
Antibiotic
Antifungal agent
Chronic
Periodontal disease
Treatment
Periodontitis
Surgery
Amoxicillin
Parasiticide
Clinical trial
Metronidazole
Antibacterial agent
Language English
License http://onlinelibrary.wiley.com/termsAndConditions#vor
CC BY 4.0
2012 John Wiley & Sons A/S.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4944-f0ae4d2dcd4604ebe202c563fb9a4ac3fdcc8a7cdc53fd9bdea59be5837854e43
Notes Fundação de Amparo à Pesquisa do Estado de São Paulo
istex:49D1B7CE8A398C48EC7407F9F41AB863536FF47F
ArticleID:JCPE12004
Table S1. Demographic characteristics and mean (±SD) full-mouth clinical parameters at baseline in the six experimental groups.Table S2. Mean number and mean percentage (± SD) of sites with PD ≥5 mm (with BOP) at baseline and at follow-up visits.
ark:/67375/WNG-VLGW280S-N
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 14
ObjectType-Article-1
ObjectType-Feature-2
content type line 23
ObjectType-Undefined-3
OpenAccessLink https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jcpe.12004
PMID 23016867
PQID 1433872666
PQPubID 105484
PageCount 10
ParticipantIDs proquest_miscellaneous_1171865762
proquest_journals_1433872666
pubmed_primary_23016867
pascalfrancis_primary_26674088
crossref_citationtrail_10_1111_jcpe_12004
crossref_primary_10_1111_jcpe_12004
wiley_primary_10_1111_jcpe_12004_JCPE12004
istex_primary_ark_67375_WNG_VLGW280S_N
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate December 2012
PublicationDateYYYYMMDD 2012-12-01
PublicationDate_xml – month: 12
  year: 2012
  text: December 2012
PublicationDecade 2010
PublicationPlace Oxford
PublicationPlace_xml – name: Oxford
– name: United States
– name: Malden
PublicationTitle Journal of clinical periodontology
PublicationTitleAlternate J Clin Periodontol
PublicationYear 2012
Publisher Blackwell Publishing Ltd
Blackwell
Publisher_xml – name: Blackwell Publishing Ltd
– name: Blackwell
References Goodson, J. M., Haffajee, A. D., Socransky, S. S., Kent, R., Teles, R., Hasturk, H., Bogren, A., Van Dyke, T., Wennstrom, J. & Lindhe, L. (2012) Control of periodontal infections: a randomized controlled trial I. The primary outcome attachment gain and pocket depth reduction at treated sites. Journal of Clinical Periodontology 39, 525-536.
Loesche, W. J., Schmidt, E., Smith, B. A., Morrison, E. C., Caffesse, R. & Hujoel, P. P. (1991) Effects of metronidazole on periodontal treatment needs. Journal of Periodontology 62, 247-257.
Loesche, W. J., Giordano, J. R., Soehren, S. & Kaciroti, N. (2005) The nonsurgical treatment of patients with periodontal disease: results after 6.4 years. General Dentistry 53, 298-306.
Pihlstrom, B. L. & Barnett, M. L. (2010) Design, operation, and interpretation of clinical trials. Journal of Dental Research 89, 759-772.
Greenstein, G. (2003) Clinical versus statistical significance as they relate to the efficacy of periodontal therapy. The Journal of the American Dental Association 5, 583-591.
Guerrero, A., Griffiths, G. S., Nibali, L., Suvan, J., Moles, D. R., Laurell, L. & Tonetti, M. S. (2005) Adjunctive benefits of systemic amoxicillin and metronidazole in non-surgical treatment of generalized aggressive periodontitis: a randomized placebo-controlled clinical trial. Journal of Clinical Periodontololgy 32, 1096-1107.
Mestnik, M. J., Feres, M., Figueiredo, L. C., Duarte, P. M., Lira, E. A. G. & Faveri, M. (2010) Short-term benefits of the adjunctive use of metronidazole plus amoxicillin in the microbial profile and in clinical parameters of subjects with generalized aggressive periodontitis. Journal of Clinical Periodontology 37, 353-365.
Armitage, G. C. (1999) Development of a classification system for periodontal disease and conditions. Annals of Periodontology 4, 1-6.
Yek, E. C., Cintan, S., Topcuoglu, N., Kulekci, G., Issever, H. & Kantarci, A. (2010) Efficacy of amoxicillin and metronidazole combination for the management of generalized aggressive periodontitis. Journal of Periodontology 81, 964-974.
Ehmke, B., Moter, A., Beikler, T., Milian, E. & Flemmig, T.F. (2005) Adjunctive antimicrobial therapy of periodontitis: long term effects on disease progression and oral colonization. Journal of Periodontology 76, 749-759.
Aimetti, M., Romano, F., Guzzi, N. & Carnevale, G. (2012) Full-mouth disinfection and systemic antimicrobial therapy in generalized aggressive periodontitis: a randomized, placebo-controlled trial. Journal of Clinical Periodontology 39, 284-294.
Herrera, D., Sanz, M., Jepsen, S., Needleman, I. & Roldan, S. (2002) A systematic review on the effect of systemic antimicrobials as an adjunct to scaling and root planing in periodontitis patients. Journal of Clinical Periodontology 29, 136-159.
Loesche, W. J., Syed, S. A., Morrison, E. C., Kerry, G. A., Higgins, T. & Stoll, J. (1984) Metronidazole in periodontitis. I. Clinical and bacteriological results after 15 to 30 weeks. Journal of Periodontology 55, 325-335.
Carvalho, L. H., D'Avila, G. B., Leao, A., Haffajee, A. D., Socransky, S. S. & Feres, M. (2004) Scaling and root planing, systemic metronidazole and professional plaque removal in the treatment of chronic periodontitis in a Brazilian population. I. clinical results. Journal of Clinical Periodontology 31, 1070-1076.
Feres, M., Haffajee, A. D., Allard, K., Som, S. & Socransky, S. S. (2001) Change in subgingival microbial profiles in adult periodontitis subjects receiving either systemically-administered amoxicillin or metronidazole. Journal of Clinical Periodontology 28, 597-609.
Rooney, J., Wade, W. G., Sprague, S. V., Newcombe, R. G. & Addy, M. (2002) Adjunctive effects to non-surgical periodontal therapy of systemic metronidazole and amoxicillin alone and combined. A placebo controlled study. Journal of Clinical Periodontology 29, 342-350.
Cionca, N., Giannopoulou, C., Ugolotti, G. & Mombelli, A. (2009) Amoxicillin and metronidazole as an adjunct to full-mouth scaling and root planing of chronic periodontitis. Journal of Periodontology 80, 364-371.
Feres, M., Gursky, L. C., Faveri, M., Tsuzuki, C.O. & Figueiredo, L. C. (2009) Clinical and microbiological benefits of strict supragingival plaque control as part of the active phase of periodontal therapy. Journal of Clinical Periodontology 36, 857-867.
Haffajee, A. D., Torresyap, G. & Socransky, S. S. (2007) Clinical changes following four different periodontal therapies for the treatment of chronic periodontitis: 1 year results. Journal of Clinical Periodontololgy 34, 243-253.
Loesche, W. J., Schmidt, E., Smith, B. A., Caffessee, R. & Stoll, J. (1987) Metronidazole therapy for periodontitis. Journal of Periodontal Research 22, 224-226.
Haffajee, A.D., Arguello, E.I., Ximenez-Fyvie, L.A. & Socransky, S.S. (2003b) Controlling the plaque biofilm. International Dental Journal 53, 191-199.
Xajigeorgiou, C., Sakellari, D., Slini, T., Baka, A. & Konstantinidis, A. (2006) Clinical and microbiological effects of different antimicrobials on generalized aggressive periodontitis. Journal of Clinical Periodontology 33, 254-264.
Silva, M. P., Feres, M., Sirotto, T. A., Soares, G. M., Mendes, J. A., Faveri, M. & Figueiredo, L. C. (2011) Clinical and microbiological benefits of metronidazole alone or with amoxicillin as adjuncts in the treatment of chronic periodontitis: a randomized placebo-controlled clinical trial. Journal of Clinical Periodontology, 38, 828-837.
Lang, N. P. & Tonetti, M. S. (2003) Periodontal risk assessment (PRA) for patients in supportive periodontal therapy (SPT). Oral Health & Preventive Dentistry 1, 7-16.
Matuliene, G., Studer, R., Lang, N. P., Schmidlin, K., Pjetursson, B. E., Salvi, G. E., Brägger, U. & Zwahlen, M. (2010) Significance of periodontal risk assessment in the recurrence of periodontitis and tooth loss. Journal of Clinical Periodontology 37, 191-199.
Matuliene, G., Pjetursson, B. E., Salvi, G. E., Schmidlin, K., Bragger, U., Zwahlen, M. & Lang, N. P. (2008) Influence of residual pockets on progression of periodontitis and tooth loss: results after 11 years of maintenance. Journal of Clinical Periodontology 35, 685-695.
Haffajee, A. D., Socransky, S. S. & Gunsolley, J. C. (2003a) Systemic anti-infective periodontal therapy. A systematic review. The American Academy of Periodontology 8, 115-181.
Matarazzo, F., Figueiredo, L. C., Cruz, S. E., Faveri, M. & Feres, M. (2008) Clinical and microbiological benefits of systemic metronidazole and amoxicillin in the treatment of smokers with chronic periodontitis: a randomized placebo-controlled study. Journal of Clinical Periodontology 35, 885-896.
Sampaio, E., Rocha, M., Figueiredo, L. C., Faveri, M., Duarte, P. M., Gomes Lira, E. A. & Feres, M. (2011) Clinical and microbiological effects of azithromycin in the treatment of generalized chronic periodontitis: a randomized placebo-controlled clinical trial. Journal of Clinical Periodontology 38, 838-846.
Winkel, E. G., van Winkelhoff, A. J., Timmerman, M. F., van der Velden, U. & van der Weijden, G. A. (2001) Amoxicillin plus metronidazole in the treatment of adult periodontitis patients. A double-blind placebo controlled study. Journal of Clinical Periodontology 28, 296-305.
van Winkelhoff, A. J., Rodenburg, J. P., Goené, R. J., Abbas, F., Winkel, E. G. & De Graaff, J. (1989) Metronidazole plus amoxicillin in the treatment of Actinobacillus actinomycetemcomitans associated periodontitis. Journal of Clinical Periodontology 16, 128-131.
2010; 37
2009; 80
2006; 33
2008; 35
1999; 4
2012; 39
2001; 28
2010; 81
2003a; 8
2011; 38
2007; 34
2010; 89
2009; 36
1987; 22
2004; 31
2002; 29
2003b; 53
1984; 55
1991; 62
2005; 53
2005; 76
2003; 5
2005; 32
2003; 1
1989; 16
e_1_2_6_32_1
e_1_2_6_10_1
e_1_2_6_31_1
e_1_2_6_30_1
e_1_2_6_19_1
e_1_2_6_13_1
e_1_2_6_14_1
e_1_2_6_11_1
Lang N. P. (e_1_2_6_16_1) 2003; 1
e_1_2_6_12_1
e_1_2_6_18_1
e_1_2_6_15_1
e_1_2_6_21_1
e_1_2_6_20_1
e_1_2_6_9_1
Loesche W. J. (e_1_2_6_17_1) 2005; 53
e_1_2_6_8_1
e_1_2_6_5_1
e_1_2_6_4_1
e_1_2_6_7_1
e_1_2_6_6_1
e_1_2_6_25_1
e_1_2_6_24_1
e_1_2_6_3_1
e_1_2_6_23_1
e_1_2_6_2_1
e_1_2_6_22_1
e_1_2_6_29_1
e_1_2_6_28_1
e_1_2_6_27_1
e_1_2_6_26_1
23773466 - J Evid Based Dent Pract. 2013 Jun;13(2):52-4
References_xml – reference: Yek, E. C., Cintan, S., Topcuoglu, N., Kulekci, G., Issever, H. & Kantarci, A. (2010) Efficacy of amoxicillin and metronidazole combination for the management of generalized aggressive periodontitis. Journal of Periodontology 81, 964-974.
– reference: Carvalho, L. H., D'Avila, G. B., Leao, A., Haffajee, A. D., Socransky, S. S. & Feres, M. (2004) Scaling and root planing, systemic metronidazole and professional plaque removal in the treatment of chronic periodontitis in a Brazilian population. I. clinical results. Journal of Clinical Periodontology 31, 1070-1076.
– reference: Matuliene, G., Pjetursson, B. E., Salvi, G. E., Schmidlin, K., Bragger, U., Zwahlen, M. & Lang, N. P. (2008) Influence of residual pockets on progression of periodontitis and tooth loss: results after 11 years of maintenance. Journal of Clinical Periodontology 35, 685-695.
– reference: Goodson, J. M., Haffajee, A. D., Socransky, S. S., Kent, R., Teles, R., Hasturk, H., Bogren, A., Van Dyke, T., Wennstrom, J. & Lindhe, L. (2012) Control of periodontal infections: a randomized controlled trial I. The primary outcome attachment gain and pocket depth reduction at treated sites. Journal of Clinical Periodontology 39, 525-536.
– reference: Silva, M. P., Feres, M., Sirotto, T. A., Soares, G. M., Mendes, J. A., Faveri, M. & Figueiredo, L. C. (2011) Clinical and microbiological benefits of metronidazole alone or with amoxicillin as adjuncts in the treatment of chronic periodontitis: a randomized placebo-controlled clinical trial. Journal of Clinical Periodontology, 38, 828-837.
– reference: Loesche, W. J., Giordano, J. R., Soehren, S. & Kaciroti, N. (2005) The nonsurgical treatment of patients with periodontal disease: results after 6.4 years. General Dentistry 53, 298-306.
– reference: Lang, N. P. & Tonetti, M. S. (2003) Periodontal risk assessment (PRA) for patients in supportive periodontal therapy (SPT). Oral Health & Preventive Dentistry 1, 7-16.
– reference: Ehmke, B., Moter, A., Beikler, T., Milian, E. & Flemmig, T.F. (2005) Adjunctive antimicrobial therapy of periodontitis: long term effects on disease progression and oral colonization. Journal of Periodontology 76, 749-759.
– reference: Herrera, D., Sanz, M., Jepsen, S., Needleman, I. & Roldan, S. (2002) A systematic review on the effect of systemic antimicrobials as an adjunct to scaling and root planing in periodontitis patients. Journal of Clinical Periodontology 29, 136-159.
– reference: Cionca, N., Giannopoulou, C., Ugolotti, G. & Mombelli, A. (2009) Amoxicillin and metronidazole as an adjunct to full-mouth scaling and root planing of chronic periodontitis. Journal of Periodontology 80, 364-371.
– reference: Pihlstrom, B. L. & Barnett, M. L. (2010) Design, operation, and interpretation of clinical trials. Journal of Dental Research 89, 759-772.
– reference: Matuliene, G., Studer, R., Lang, N. P., Schmidlin, K., Pjetursson, B. E., Salvi, G. E., Brägger, U. & Zwahlen, M. (2010) Significance of periodontal risk assessment in the recurrence of periodontitis and tooth loss. Journal of Clinical Periodontology 37, 191-199.
– reference: Feres, M., Gursky, L. C., Faveri, M., Tsuzuki, C.O. & Figueiredo, L. C. (2009) Clinical and microbiological benefits of strict supragingival plaque control as part of the active phase of periodontal therapy. Journal of Clinical Periodontology 36, 857-867.
– reference: Matarazzo, F., Figueiredo, L. C., Cruz, S. E., Faveri, M. & Feres, M. (2008) Clinical and microbiological benefits of systemic metronidazole and amoxicillin in the treatment of smokers with chronic periodontitis: a randomized placebo-controlled study. Journal of Clinical Periodontology 35, 885-896.
– reference: Mestnik, M. J., Feres, M., Figueiredo, L. C., Duarte, P. M., Lira, E. A. G. & Faveri, M. (2010) Short-term benefits of the adjunctive use of metronidazole plus amoxicillin in the microbial profile and in clinical parameters of subjects with generalized aggressive periodontitis. Journal of Clinical Periodontology 37, 353-365.
– reference: Aimetti, M., Romano, F., Guzzi, N. & Carnevale, G. (2012) Full-mouth disinfection and systemic antimicrobial therapy in generalized aggressive periodontitis: a randomized, placebo-controlled trial. Journal of Clinical Periodontology 39, 284-294.
– reference: Armitage, G. C. (1999) Development of a classification system for periodontal disease and conditions. Annals of Periodontology 4, 1-6.
– reference: Loesche, W. J., Syed, S. A., Morrison, E. C., Kerry, G. A., Higgins, T. & Stoll, J. (1984) Metronidazole in periodontitis. I. Clinical and bacteriological results after 15 to 30 weeks. Journal of Periodontology 55, 325-335.
– reference: Haffajee, A. D., Socransky, S. S. & Gunsolley, J. C. (2003a) Systemic anti-infective periodontal therapy. A systematic review. The American Academy of Periodontology 8, 115-181.
– reference: Xajigeorgiou, C., Sakellari, D., Slini, T., Baka, A. & Konstantinidis, A. (2006) Clinical and microbiological effects of different antimicrobials on generalized aggressive periodontitis. Journal of Clinical Periodontology 33, 254-264.
– reference: Loesche, W. J., Schmidt, E., Smith, B. A., Caffessee, R. & Stoll, J. (1987) Metronidazole therapy for periodontitis. Journal of Periodontal Research 22, 224-226.
– reference: Guerrero, A., Griffiths, G. S., Nibali, L., Suvan, J., Moles, D. R., Laurell, L. & Tonetti, M. S. (2005) Adjunctive benefits of systemic amoxicillin and metronidazole in non-surgical treatment of generalized aggressive periodontitis: a randomized placebo-controlled clinical trial. Journal of Clinical Periodontololgy 32, 1096-1107.
– reference: Loesche, W. J., Schmidt, E., Smith, B. A., Morrison, E. C., Caffesse, R. & Hujoel, P. P. (1991) Effects of metronidazole on periodontal treatment needs. Journal of Periodontology 62, 247-257.
– reference: Winkel, E. G., van Winkelhoff, A. J., Timmerman, M. F., van der Velden, U. & van der Weijden, G. A. (2001) Amoxicillin plus metronidazole in the treatment of adult periodontitis patients. A double-blind placebo controlled study. Journal of Clinical Periodontology 28, 296-305.
– reference: Feres, M., Haffajee, A. D., Allard, K., Som, S. & Socransky, S. S. (2001) Change in subgingival microbial profiles in adult periodontitis subjects receiving either systemically-administered amoxicillin or metronidazole. Journal of Clinical Periodontology 28, 597-609.
– reference: Greenstein, G. (2003) Clinical versus statistical significance as they relate to the efficacy of periodontal therapy. The Journal of the American Dental Association 5, 583-591.
– reference: van Winkelhoff, A. J., Rodenburg, J. P., Goené, R. J., Abbas, F., Winkel, E. G. & De Graaff, J. (1989) Metronidazole plus amoxicillin in the treatment of Actinobacillus actinomycetemcomitans associated periodontitis. Journal of Clinical Periodontology 16, 128-131.
– reference: Haffajee, A.D., Arguello, E.I., Ximenez-Fyvie, L.A. & Socransky, S.S. (2003b) Controlling the plaque biofilm. International Dental Journal 53, 191-199.
– reference: Sampaio, E., Rocha, M., Figueiredo, L. C., Faveri, M., Duarte, P. M., Gomes Lira, E. A. & Feres, M. (2011) Clinical and microbiological effects of azithromycin in the treatment of generalized chronic periodontitis: a randomized placebo-controlled clinical trial. Journal of Clinical Periodontology 38, 838-846.
– reference: Haffajee, A. D., Torresyap, G. & Socransky, S. S. (2007) Clinical changes following four different periodontal therapies for the treatment of chronic periodontitis: 1 year results. Journal of Clinical Periodontololgy 34, 243-253.
– reference: Rooney, J., Wade, W. G., Sprague, S. V., Newcombe, R. G. & Addy, M. (2002) Adjunctive effects to non-surgical periodontal therapy of systemic metronidazole and amoxicillin alone and combined. A placebo controlled study. Journal of Clinical Periodontology 29, 342-350.
– volume: 37
  start-page: 353
  year: 2010
  end-page: 365
  article-title: Short‐term benefits of the adjunctive use of metronidazole plus amoxicillin in the microbial profile and in clinical parameters of subjects with generalized aggressive periodontitis
  publication-title: Journal of Clinical Periodontology
– volume: 22
  start-page: 224
  year: 1987
  end-page: 226
  article-title: Metronidazole therapy for periodontitis
  publication-title: Journal of Periodontal Research
– volume: 39
  start-page: 525
  year: 2012
  end-page: 536
  article-title: Control of periodontal infections: a randomized controlled trial I. The primary outcome attachment gain and pocket depth reduction at treated sites
  publication-title: Journal of Clinical Periodontology
– volume: 1
  start-page: 7
  year: 2003
  end-page: 16
  article-title: Periodontal risk assessment (PRA) for patients in supportive periodontal therapy (SPT)
  publication-title: Oral Health & Preventive Dentistry
– volume: 33
  start-page: 254
  year: 2006
  end-page: 264
  article-title: Clinical and microbiological effects of different antimicrobials on generalized aggressive periodontitis
  publication-title: Journal of Clinical Periodontology
– volume: 34
  start-page: 243
  year: 2007
  end-page: 253
  article-title: Clinical changes following four different periodontal therapies for the treatment of chronic periodontitis: 1 year results
  publication-title: Journal of Clinical Periodontololgy
– volume: 38
  start-page: 828
  year: 2011
  end-page: 837
  article-title: Clinical and microbiological benefits of metronidazole alone or with amoxicillin as adjuncts in the treatment of chronic periodontitis: a randomized placebo‐controlled clinical trial
  publication-title: Journal of Clinical Periodontology
– volume: 35
  start-page: 685
  year: 2008
  end-page: 695
  article-title: Influence of residual pockets on progression of periodontitis and tooth loss: results after 11 years of maintenance
  publication-title: Journal of Clinical Periodontology
– volume: 5
  start-page: 583
  year: 2003
  end-page: 591
  article-title: Clinical versus statistical significance as they relate to the efficacy of periodontal therapy
  publication-title: The Journal of the American Dental Association
– volume: 4
  start-page: 1
  year: 1999
  end-page: 6
  article-title: Development of a classification system for periodontal disease and conditions
  publication-title: Annals of Periodontology
– volume: 38
  start-page: 838
  year: 2011
  end-page: 846
  article-title: Clinical and microbiological effects of azithromycin in the treatment of generalized chronic periodontitis: a randomized placebo‐controlled clinical trial
  publication-title: Journal of Clinical Periodontology
– volume: 80
  start-page: 364
  year: 2009
  end-page: 371
  article-title: Amoxicillin and metronidazole as an adjunct to full‐mouth scaling and root planing of chronic periodontitis
  publication-title: Journal of Periodontology
– volume: 28
  start-page: 597
  year: 2001
  end-page: 609
  article-title: Change in subgingival microbial profiles in adult periodontitis subjects receiving either systemically‐administered amoxicillin or metronidazole
  publication-title: Journal of Clinical Periodontology
– volume: 55
  start-page: 325
  year: 1984
  end-page: 335
  article-title: Metronidazole in periodontitis. I. Clinical and bacteriological results after 15 to 30 weeks
  publication-title: Journal of Periodontology
– volume: 8
  start-page: 115
  year: 2003a
  end-page: 181
  article-title: Systemic anti‐infective periodontal therapy. A systematic review
  publication-title: The American Academy of Periodontology
– volume: 62
  start-page: 247
  year: 1991
  end-page: 257
  article-title: Effects of metronidazole on periodontal treatment needs
  publication-title: Journal of Periodontology
– volume: 29
  start-page: 136
  year: 2002
  end-page: 159
  article-title: A systematic review on the effect of systemic antimicrobials as an adjunct to scaling and root planing in periodontitis patients
  publication-title: Journal of Clinical Periodontology
– volume: 53
  start-page: 298
  year: 2005
  end-page: 306
  article-title: The nonsurgical treatment of patients with periodontal disease: results after 6.4 years
  publication-title: General Dentistry
– volume: 37
  start-page: 191
  year: 2010
  end-page: 199
  article-title: Significance of periodontal risk assessment in the recurrence of periodontitis and tooth loss
  publication-title: Journal of Clinical Periodontology
– volume: 89
  start-page: 759
  year: 2010
  end-page: 772
  article-title: Design, operation, and interpretation of clinical trials
  publication-title: Journal of Dental Research
– volume: 35
  start-page: 885
  year: 2008
  end-page: 896
  article-title: Clinical and microbiological benefits of systemic metronidazole and amoxicillin in the treatment of smokers with chronic periodontitis: a randomized placebo‐controlled study
  publication-title: Journal of Clinical Periodontology
– volume: 81
  start-page: 964
  year: 2010
  end-page: 974
  article-title: Efficacy of amoxicillin and metronidazole combination for the management of generalized aggressive periodontitis
  publication-title: Journal of Periodontology
– volume: 39
  start-page: 284
  year: 2012
  end-page: 294
  article-title: Full‐mouth disinfection and systemic antimicrobial therapy in generalized aggressive periodontitis: a randomized, placebo‐controlled trial
  publication-title: Journal of Clinical Periodontology
– volume: 36
  start-page: 857
  year: 2009
  end-page: 867
  article-title: Clinical and microbiological benefits of strict supragingival plaque control as part of the active phase of periodontal therapy
  publication-title: Journal of Clinical Periodontology
– volume: 29
  start-page: 342
  year: 2002
  end-page: 350
  article-title: Adjunctive effects to non‐surgical periodontal therapy of systemic metronidazole and amoxicillin alone and combined. A placebo controlled study
  publication-title: Journal of Clinical Periodontology
– volume: 76
  start-page: 749
  year: 2005
  end-page: 759
  article-title: Adjunctive antimicrobial therapy of periodontitis: long term effects on disease progression and oral colonization
  publication-title: Journal of Periodontology
– volume: 32
  start-page: 1096
  year: 2005
  end-page: 1107
  article-title: Adjunctive benefits of systemic amoxicillin and metronidazole in non‐surgical treatment of generalized aggressive periodontitis: a randomized placebo‐controlled clinical trial
  publication-title: Journal of Clinical Periodontololgy
– volume: 31
  start-page: 1070
  year: 2004
  end-page: 1076
  article-title: Scaling and root planing, systemic metronidazole and professional plaque removal in the treatment of chronic periodontitis in a Brazilian population. I. clinical results
  publication-title: Journal of Clinical Periodontology
– volume: 16
  start-page: 128
  year: 1989
  end-page: 131
  article-title: Metronidazole plus amoxicillin in the treatment of Actinobacillus actinomycetemcomitans associated periodontitis
  publication-title: Journal of Clinical Periodontology
– volume: 53
  start-page: 191
  year: 2003b
  end-page: 199
  article-title: Controlling the plaque biofilm
  publication-title: International Dental Journal
– volume: 28
  start-page: 296
  year: 2001
  end-page: 305
  article-title: Amoxicillin plus metronidazole in the treatment of adult periodontitis patients. A double‐blind placebo controlled study
  publication-title: Journal of Clinical Periodontology
– ident: e_1_2_6_21_1
  doi: 10.1111/j.1600-051X.2008.01304.x
– ident: e_1_2_6_18_1
  doi: 10.1111/j.1600-0765.1987.tb01574.x
– ident: e_1_2_6_19_1
  doi: 10.1902/jop.1991.62.4.247
– ident: e_1_2_6_20_1
  doi: 10.1902/jop.1984.55.6.325
– ident: e_1_2_6_25_1
  doi: 10.1177/0022034510374737
– ident: e_1_2_6_12_1
  doi: 10.1902/annals.2003.8.1.115
– ident: e_1_2_6_4_1
  doi: 10.1111/j.1600-051X.2004.00605.x
– ident: e_1_2_6_8_1
  doi: 10.1034/j.1600-051x.2001.028007597.x
– ident: e_1_2_6_32_1
  doi: 10.1902/jop.2010.090522
– volume: 53
  start-page: 298
  year: 2005
  ident: e_1_2_6_17_1
  article-title: The nonsurgical treatment of patients with periodontal disease: results after 6.4 years
  publication-title: General Dentistry
– ident: e_1_2_6_31_1
  doi: 10.1111/j.1600-051X.2006.00905.x
– ident: e_1_2_6_5_1
  doi: 10.1902/jop.2009.080540
– ident: e_1_2_6_28_1
  doi: 10.1111/j.1600-051X.2011.01763.x
– ident: e_1_2_6_22_1
  doi: 10.1111/j.1600-051X.2008.01245.x
– ident: e_1_2_6_15_1
  doi: 10.1034/j.1600-051X.29.s3.8.x
– ident: e_1_2_6_13_1
  doi: 10.1111/j.1875-595X.2003.tb00770.x
– volume: 1
  start-page: 7
  year: 2003
  ident: e_1_2_6_16_1
  article-title: Periodontal risk assessment (PRA) for patients in supportive periodontal therapy (SPT)
  publication-title: Oral Health & Preventive Dentistry
– ident: e_1_2_6_10_1
  doi: 10.14219/jada.archive.2003.0225
– ident: e_1_2_6_29_1
  doi: 10.1034/j.1600-051x.2001.028004296.x
– ident: e_1_2_6_2_1
  doi: 10.1111/j.1600-051X.2011.01795.x
– ident: e_1_2_6_7_1
  doi: 10.1111/j.1600-051X.2009.01471.x
– ident: e_1_2_6_9_1
  doi: 10.1111/j.1600-051X.2012.01870.x
– ident: e_1_2_6_11_1
  doi: 10.1111/j.1600-051X.2005.00814.x
– ident: e_1_2_6_14_1
  doi: 10.1111/j.1600-051X.2006.01040.x
– ident: e_1_2_6_23_1
  doi: 10.1111/j.1600-051X.2009.01508.x
– ident: e_1_2_6_3_1
  doi: 10.1902/annals.1999.4.1.1
– ident: e_1_2_6_26_1
  doi: 10.1034/j.1600-051X.2002.290410.x
– ident: e_1_2_6_30_1
  doi: 10.1111/j.1600-051X.1989.tb01626.x
– ident: e_1_2_6_27_1
  doi: 10.1111/j.1600-051X.2011.01766.x
– ident: e_1_2_6_6_1
  doi: 10.1902/jop.2005.76.5.749
– ident: e_1_2_6_24_1
  doi: 10.1111/j.1600-051X.2010.01538.x
– reference: 23773466 - J Evid Based Dent Pract. 2013 Jun;13(2):52-4
SSID ssj0017333
Score 2.4043808
Snippet Aim To evaluate the effects of the adjunctive use of metronidazole (MTZ) or MTZ + amoxicillin (AMX) in the treatment of generalized chronic periodontitis...
View the pubcast on this paper at http://scivee-1.sdsc.edu/node/55261
To evaluate the effects of the adjunctive use of metronidazole (MTZ) or MTZ + amoxicillin (AMX) in the treatment of generalized chronic periodontitis (ChP). A...
Aim To evaluate the effects of the adjunctive use of metronidazole (MTZ) or MTZ + amoxicillin (AMX) in the treatment of generalized chronic periodontitis...
To evaluate the effects of the adjunctive use of metronidazole (MTZ) or MTZ + amoxicillin (AMX) in the treatment of generalized chronic periodontitis (ChP). A...
SourceID proquest
pubmed
pascalfrancis
crossref
wiley
istex
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1149
SubjectTerms Adult
amoxicillin
Amoxicillin - adverse effects
Amoxicillin - therapeutic use
Analysis of Variance
Anti-Bacterial Agents - adverse effects
Anti-Bacterial Agents - therapeutic use
Antibiotics
Antibiotics. Antiinfectious agents. Antiparasitic agents
Antifungal agents
Antiparasitic agents
Biological and medical sciences
Chemotherapy, Adjuvant
Chlorhexidine - therapeutic use
chronic periodontitis
Chronic Periodontitis - drug therapy
Clinical outcomes
Dental Scaling
Dentistry
Double-Blind Method
Drug Combinations
Facial bones, jaws, teeth, parodontium: diseases, semeiology
Female
Humans
Logistic Models
Longitudinal Studies
Male
Medical sciences
metronidazole
Metronidazole - therapeutic use
Middle Aged
Mouthwashes - therapeutic use
Non tumoral diseases
Otorhinolaryngology. Stomatology
periodontal disease
Periodontal Index
Periodontal Pocket - drug therapy
Periodontal Pocket - pathology
periodontal treatment
Pharmacology. Drug treatments
scaling and root planing
Statistics, Nonparametric
Treatment Outcome
Title Metronidazole alone or with amoxicillin as adjuncts to non-surgical treatment of chronic periodontitis: a 1-year double-blinded, placebo-controlled, randomized clinical trial
URI https://api.istex.fr/ark:/67375/WNG-VLGW280S-N/fulltext.pdf
https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fjcpe.12004
https://www.ncbi.nlm.nih.gov/pubmed/23016867
https://www.proquest.com/docview/1433872666
https://www.proquest.com/docview/1171865762
Volume 39
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3LbtQwFLWqsoAN70egVEYgJBAZTRLbSRAb1KcqOkJAaTco8itSaRpXk0Qqs-IT-Bo-iC_h2k4Cgyok2GUy16Nc577sOT4XoSeplnEmKAtVrnRIlMhDrjgLZRlZPilImMqeRt6fsd0DsndEj1bQq-EsjOeHGDfcrGe4eG0dnIvmdyeXZ3oSxZ4MNEqYJc7ffDdyR0Vp4vvIQ4wOWZ7mPTepg_GMQ5ey0SU7secWHckbmKDSd7a4qPRcrmRdKtq-hj4NSngEysmka8VELv7gd_xfLa-jq32Nil97o7qBVnR9E13etLgi2xruFvq-r13rHMUXptKYV6bW2Myx3dTF_NScH0u7jVNj3mCuPkPqbBvcGlyb-sfXb003d-EWjyB3bEosPUsvtszLsFR2VK_NS8xxBEO-gD9iZTpRafgkKsvxqF5gBygTBm71iPvK3oUJVeb0eKEVHs59Ytec5DY62N76sLEb9g0gQklyQsJyyjVRsZKKsCkBc4unsaQsKUXOCZdJqaTMeCqVpHCdC6U5zYWmliSfEk2SO2gVNNP3EE5SDVJCC6oiUgqSJYrRqMwJLOko4VGAng2GUMieHd026aiKcZUEb6JwbyJAj0fZM88JcqHUU2dPowifn1gUXUqLw9lO8fHNzmGcTd8XswCtLxncOABqpxSeLwvQ2mCBRR9hGliyJUmWgggL0KPxa4gN9g8fXmvTNZbIPQL1IN8F6K633F8_DpGdZSwN0HNnf3_RpNjbeLvlru7_i_ADdAWqy9hjf9bQajvv9EOo4Fqx7jz1J3kbSpU
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3LbtNAFB2hdlE2UN6mpQwCIYFwFNszfrBDfYWSRAha2p01L0ulrqeKE6lkxSfwNXwQX8K9Y8cQVCHBznHuRJ7xfU7OnEvIs8SoMJU89nWmjc-0zHyhReyrIkA-KQiYGk8jj8bx4IgdnPCTFpuDZ2Eafohuww0tw_lrNHDckP7dytWF6QWhYwNdZZBpYO2186FjjwqSqOkkD17aj7Mka9lJHZCnG7sUj1ZxaS8RHylqWKKi6W1xVfK5nMu6YLR3s-m4WjsOQ8SgnPVmU9lT8z8YHv97nuvkRpum0jeNXt0i10x1m6ztILQIu8PdId9HxnXP0WJuS0NFaStD7YTivi4V5_byVOFOTkVFTYX-DNFzWtOppZWtfnz9Vs8mzuPSDudObUFVQ9RLkXwZqmXH9lq_poIGMOQLmCTVdiZLA59kiTSP-hV1mDJp4VYLui_xLqyotuenc6Pp4ugndf1J7pKjvd3D7YHf9oDwFcsY84u-MEyHWmkW9xloXNgPFY-jQmaCCRUVWqlUJEorDteZ1EbwTBqOPPmcGRbdIyswM_OA0CgxICWN5DpghWRppGMeFBmDqo4zEXjkxUITctUSpGOfjjLvCiV4E7l7Ex552sleNLQgV0o9dwrViYjJGQLpEp4fj_fzT8P94zDtf8zHHtla0rhuAKRPCTxf6pHNhQrmrZOpoWqLojQBkdgjT7qvwT3gfz6iMnZWI5d7ANODkOeR-43q_vpxcO5xGiceeekU8C8zyQ-23--6q4f_IvyYrA0OR8N8-Hb8boNch2QzbKBAm2RlOpmZR5DQTeWWM9uf48NOtA
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Zb9QwEB5VrQS8cB-BUoxASCCy2iR2DsQLarstpV1VQI8XFPmKVJrGq82uVPaJn8Cv4QfxSxg72cCiCgneEmccZey57Iy_AXiaaBmmgsW-ypT2qRKZzxWPfVkEFk8KHaayp5H3hvH2Ad05ZsdL8Hp-FqbBh-g23KxmOHttFXykit-VXI50LwgdGOgKjTGUsCHR-w48KkiippA8Gmk_zpKsBSd1eTxd3wV3tGJH9tymR_IaR6hoSltcFHsuhrLOFw2uwac5F00KymlvOhE9OfsD4PF_2bwOV9sglbxppOoGLOnqJlzesIlFtjbcLfi-p13tHMVnptSEl6bSxIyJ3dUl_Mycn0i7j1MRXhOuPqPvnNRkYkhlqh9fv9XTsbO3pMtyJ6YgsoHpJRZ6GdfKDuu1fkU4CbDLF1RIosxUlBrvRGlBHtVL4jLKhMGmNuW-tK04oMqcncy0IvODn8RVJ7kNB4PNj-vbflsBwpc0o9Qv-lxTFSqpcIIpylvYDyWLo0JknHIZFUrKlCdSSYbXmVCas0xoZlHyGdU0ugPLyJm-ByRKNFIJLZgKaCFoGqmYBUVGcU3HKA88eD4XhFy28Oi2SkeZd8sknInczYQHTzraUQMKciHVMydPHQkfn9o0uoTlR8Ot_HB36yhM-x_yoQdrCwLXdcDgKcHvSz1YnUtg3pqYGtdsUZQmSBJ78Lh7jMbB_vHhlTbT2iK5B8geOjwP7jaS--vlaNrjNE48eOHk7y-c5Dvr-5vu6v6_ED-CS_sbg3z37fDdA7iCkWbY5AGtwvJkPNUPMZqbiDWntD8B1c1NYw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Metronidazole+alone+or+with+amoxicillin+as+adjuncts+to+non-surgical+treatment+of+chronic+periodontitis%3A+a+1-year+double-blinded%2C+placebo-controlled%2C+randomized+clinical+trial&rft.jtitle=Journal+of+clinical+periodontology&rft.au=FERES%2C+Magda&rft.au=SILVA+SOARES%2C+Geisla+Mary&rft.au=VELLOSO+MENDES%2C+Juliana+Alethusa&rft.au=PAULINO+SILVA%2C+Maike&rft.date=2012-12-01&rft.pub=Blackwell&rft.issn=0303-6979&rft.volume=39&rft.issue=12&rft.spage=1149&rft.epage=1158&rft_id=info:doi/10.1111%2Fjcpe.12004&rft.externalDBID=n%2Fa&rft.externalDocID=26674088
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0303-6979&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0303-6979&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0303-6979&client=summon